JB Chemicals & Pharmaceuticals Q2 Results
- BSE: 506943
- NSE: JBCHEPHARM
- ISIN: INE572A01036
- Sector: Biotechnology & Drugs
BSE
1,750.8
16.60 (0.96%)
16.60 (0.96%)Volume2.36 K
Updated: Mon 25 Nov, 2024 | 15:29:23
NSE
1,752.59.10 (0.52%)
9.10 (0.52%)Volume96.92 K
Updated: Mon 25 Nov, 2024 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,000.62 Cr.(-0.38%)
- Operating Profit₹228.64 Cr.(-4.57%)
- Profit After Tax₹174.57 Cr.(-1.28%)
- Operating Margin22.85%(-4.68%)
Note: Comparison is on YoY basis
Quarterly - JB Chemicals & Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,000.62 | 896.20 | -% | 881.74 | -% |
| Selling/ General/ Admin Expenses Total | 170.57 | 148.75 | -% | 148.28 | -% |
| Depreciation/ Amortization | 41.88 | 31.38 | -% | 32.17 | -% |
| Other Operating Expenses Total | 221.11 | 205.37 | -% | 191.75 | -% |
| Total Operating Expense | 771.98 | 695.47 | -% | 670.37 | -% |
| Operating Income | 228.64 | 200.73 | -% | 211.37 | -% |
| Net Income Before Taxes | 236.53 | 194.30 | -% | 208.66 | -% |
| Net Income | 174.57 | 142.32 | -% | 150.59 | -% |
| Diluted Normalized EPS | 11.00 | 9.07 | -% | 9.54 | -% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST